Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stada Grows China Presence Through CR Sanjiu Partnership

Executive Summary

Stada has struck a deal with CR Sanjiu for distribution and promotion of its cough and cold brands after identifying expansion in the Chinese market as a key strategic target.

You may also be interested in...



Asia Deal Watch: Dr Reddy’s Licenses Coya’s ALS Combo Drug

Plus deals involving Abbisko/Merck & Co., Astellas/Phenomic AI, PRISM Biolab/Lilly and WuXi Biologics/Myricx.

Thinking Locally Propelling Stada CHC’s Rapid Growth In Europe

In this exclusive interview, Stada Consumer Healthcare's global head Volker Sydow discusses the company's growth ambitions for the business in Europe and further afield. Sydow outlines Stada CHC's local brand hero strategy, an approach which he says sets the firm apart from the competition. 

'Deeper And More Complex' – Nestlé CEO Bemoans VMS Supply Chain Problems

Supply problems for Nestlé’s US dietary supplement brands “were more fundamental than initially we have estimated,” according to CEO Mark Schneider. Nestlé now expects the issue – first flagged up last year – won’t be fully resolved until the end of the first half of 2024.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel